These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 2516906

  • 1. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
    Krasucka-Kluźniak A, Krakówka P.
    Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906
    [Abstract] [Full Text] [Related]

  • 2. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
    Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349
    [Abstract] [Full Text] [Related]

  • 3. [Therapeutic effect of ofloxacin on intractable pulmonary tuberculosis and ofloxacin resistance of tubercle bacilli isolated from the patients. Chest DIsease Cooperative Study Unit of National Sanatoriums in Kinki District].
    Nakae I, Nakatani K, Inoue S, Takahasi K, Ikeda N, Matsumoto T, Ozawa S, Sakatani M, Kita N, Tanaka S.
    Kekkaku; 1991 Apr; 66(4):299-307. PubMed ID: 1904960
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG, Chukanov VI, Korneev AA.
    Probl Tuberk; 1996 Apr; (6):42-4. PubMed ID: 9019768
    [Abstract] [Full Text] [Related]

  • 5. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV.
    Probl Tuberk; 1997 Apr; (2):33-5. PubMed ID: 9235582
    [Abstract] [Full Text] [Related]

  • 6. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
    Korotaev GA, Kozulitsyna TI, Tret'iakova EA, Mamed'iarova FA.
    Probl Tuberk; 1986 Nov; (7):32-6. PubMed ID: 3094001
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z.
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract] [Full Text] [Related]

  • 10. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
    Schmelev NA.
    Scand J Respir Dis Suppl; 1968 Oct; 65():147-50. PubMed ID: 4978458
    [No Abstract] [Full Text] [Related]

  • 11. [Evaluation of new antitubercular agents--new quinolone agents].
    Kawahara S, Eirei J.
    Kekkaku; 1992 Oct; 67(10):679-82. PubMed ID: 1333544
    [No Abstract] [Full Text] [Related]

  • 12. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G.
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H, Maekawa N, Nakanishi M, Kawai M, Naito M.
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Ethambutol in the treatment of chronic pulmonary tuberculosis with bacilli resistant to tuberculostatics].
    Anastasatu C, Kaufman S, Barcan F, Gheorghiu M, Cristea M, Ulpian C, Iancovici O.
    Ftiziologia; 1971 Jan; 20(4):373-9. PubMed ID: 5005706
    [No Abstract] [Full Text] [Related]

  • 17. [In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].
    Tada A, Kawata N, Shibayama T, Takahashi S, Hirano A, Kimura G, Takeuchi M, Okada C, Soda R, Takahashi K.
    Kekkaku; 2006 Apr; 81(4):337-44. PubMed ID: 16715942
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K.
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.